{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T03:03:42Z","timestamp":1773975822141,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:00:00Z","timestamp":1707436800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.htct.2023.12.007","type":"journal-article","created":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T00:15:20Z","timestamp":1708215320000},"page":"S79-S85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"S6","title":["Quantitative detection of T315I mutations of BCR::ABL1 using digital droplet polymerase chain reaction"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4352-2506","authenticated-orcid":false,"given":"Huijun","family":"Mu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3841-5856","authenticated-orcid":false,"given":"Haiping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.htct.2023.12.007_bib0001","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/s41375-018-0341-4","article-title":"The proportion of different BCR-ABL1 transcript types in chronic myeloid leukemia. An international overview","volume":"33","author":"Baccarani","year":"2019","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.htct.2023.12.007_bib0002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0265278","article-title":"Performance characteristics of the first food and drug administration (FDA)-cleared digital droplet PCR (ddPCR) assay for BCR::ABL1 monitoring in chronic myelogenous leukemia","volume":"17","author":"Shelton","year":"2022","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.htct.2023.12.007_bib0003","first-page":"364","article-title":"Clinical characteristics of chronic myeloid leukemia with T315I mutation and the efficacy of ponatinib","volume":"39","author":"Chen","year":"2019","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"10.1016\/j.htct.2023.12.007_bib0004","article-title":"T315I-mutated myeloid sarcoma","volume":"12","author":"Zhang","year":"2019","journal-title":"Leuk Res Rep"},{"key":"10.1016\/j.htct.2023.12.007_bib0005","article-title":"Mechanistic insights into co-administration of allosteric and orthosteric drugs to overcome drug-resistance in T315I BCR-ABL1","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Pharmacol"},{"issue":"12","key":"10.1016\/j.htct.2023.12.007_bib0006","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.31557\/APJCP.2018.19.12.3317","article-title":"Prevalence of BCR-ABL T315I mutation in malaysian patients with imatinib-resistant chronic myeloid leukemia","volume":"19","author":"Mat Yusoff","year":"2018","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.htct.2023.12.007_bib0007","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.2147\/OTT.S142482","article-title":"Characteristics and mutation analysis of Ph-positive leukemia patients with T315I mutation receiving tyrosine kinase inhibitors","volume":"10","author":"Xu","year":"2017","journal-title":"Onco Targets Ther"},{"issue":"2","key":"10.1016\/j.htct.2023.12.007_bib0008","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3923\/pjbs.2022.175.181","article-title":"Prevalence of BCR-ABL T315I mutation in different chronic myeloid leukemia patients categories","volume":"25","author":"Elsir Khair","year":"2022","journal-title":"Pak J Biol Sci"},{"key":"10.1016\/j.htct.2023.12.007_bib0009","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40364-015-0039-y","article-title":"Detection of BCR-ABL T315I mutation by peptide nucleic acid directed PCR clamping and by peptide nucleic acid FISH","volume":"3","author":"Rosso","year":"2015","journal-title":"Biomark Res"},{"issue":"1","key":"10.1016\/j.htct.2023.12.007_bib0010","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s40291-021-00562-2","article-title":"Current and emerging applications of droplet digital pcr in oncology: an updated review","volume":"26","author":"Olmedillas-Lopez","year":"2022","journal-title":"Mol Diagn Ther"},{"issue":"4","key":"10.1016\/j.htct.2023.12.007_bib0011","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/bjh.14082","article-title":"Comparative analysis between RQ-PCR and digital-droplet-PCR of immunoglobulin\/T-cell receptor gene rearrangements to monitor minimal residual disease in acute lymphoblastic leukaemia","volume":"174","author":"Della Starza","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.htct.2023.12.007_bib0012","article-title":"A comparison of blood pathogen detection among droplet digital PCR, metagenomic next-generation sequencing, and blood culture in critically ill patients with suspected bloodstream infections","volume":"12","author":"Hu","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.htct.2023.12.007_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101589","article-title":"Up-front mutation detection in circulating tumor DNA by droplet digital PCR has added diagnostic value in lung cancer","volume":"27","author":"Visser","year":"2023","journal-title":"Transl Oncol"},{"issue":"5","key":"10.1016\/j.htct.2023.12.007_bib0014","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3897\/folmed.63.e63366","article-title":"Clinical characteristics, disease evolution and survival in patients with chronic myeloid leukemia, BCR-ABL1 (+) and T315I mutation","volume":"63","author":"Goranova-Marinova","year":"2021","journal-title":"Folia Med (Plovdiv)"},{"issue":"2","key":"10.1016\/j.htct.2023.12.007_bib0015","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1182\/blood-2006-11-052373","article-title":"Kinase domain mutations of BCR-ABL frequently precede imatinib-based therapy and give rise to relapse in patients with de novo Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)","volume":"110","author":"Pfeifer","year":"2007","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.htct.2023.12.007_bib0016","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.3109\/10428194.2016.1144881","article-title":"Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665","volume":"57","author":"DeBoer","year":"2016","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"10.1016\/j.htct.2023.12.007_bib0017","article-title":"Digital droplet PCR in hematologic malignancies: a new useful molecular tool","volume":"12","author":"Galimberti","year":"2022","journal-title":"Diagnostics (Basel)"},{"issue":"8","key":"10.1016\/j.htct.2023.12.007_bib0018","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jmoldx.2022.04.013","article-title":"A new view on minimal residual disease quantification in acute lymphoblastic leukemia using droplet digital PCR","volume":"24","author":"Schwinghammer","year":"2022","journal-title":"J Mol Diagn"},{"issue":"2","key":"10.1016\/j.htct.2023.12.007_bib0019","first-page":"107","article-title":"Primary imatinib resistance in chronic myeloid leukemia patients in a developing country: BCR-ABL kinase domain mutations or BCR-ABL independent mechanisms?","volume":"39","author":"Yap","year":"2017","journal-title":"Malays J Pathol"},{"issue":"4","key":"10.1016\/j.htct.2023.12.007_bib0020","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/s41375-020-0776-2","article-title":"European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia","volume":"34","author":"Hochhaus","year":"2020","journal-title":"Leukemia"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137924000300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137924000300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T11:06:28Z","timestamp":1737975988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137924000300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":20,"alternative-id":["S2531137924000300"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2023.12.007","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative detection of T315I mutations of BCR::ABL1 using digital droplet polymerase chain reaction","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2023.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}